DENTSPLY SIRONA (XRAY) Form 3 DENTSPLY SIRONA / Maureen J. MacInnis ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

MacInnis Maureen J.

(Last) (First) (Middle)

221 WEST PHILADELPHIA STREET STE 60 W

(Street)

YORK PA 17401

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/07/2016

3. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Sr VP & Chief HR Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	13,530	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Supplemental Executive Retirement Plan (SERP)	(1)	(2)	Common Stock	6,637	(1)	D
RSU (Restricted Stock Unit)	(4)	(1)	Common Stock	10,749.958	0(3)	D
PRSU (Performance Measured Restricted Stock Unit)	(5)	(1)	Common Stock	5,202.8	0(3)	D
Stock Option	(6)	04/14/2019	Common Stock	17,650	26.72	D
Stock Option	(6)	12/08/2019	Common Stock	23,200	33.86	D
Stock Option	(6)	02/11/2021	Common Stock	21,900	36.62	D
Stock Option	(6)	02/21/2022	Common Stock	18,300	38.74	D
Stock Option	(6)	02/25/2023	Common Stock	13,800	40.86	D
Stock Option	(7)	02/24/2024	Common Stock	15,000	45.11	D
Stock Option	(8)	02/23/2025	Common Stock	14,800	52	D
Stock Option	(9)	02/17/2026	Common Stock	12,100	55.91	D

Explanation of Responses:

1. Non-applicable to this transaction.

2. Value paid in stock following the reporting person's retirement.

3. Shares convert to common stock on a 1:1 basis.

4. Includes: (i) 4,173 RSUs granted on 2/24/2014; (ii) 3,173 RSUs granted on 2/23/2015; and (iii) 3,327 RSUs granted on 2/17/2016, each of which shall vest in full (restrictions lapse) three years from the grant date.

5. Includes: (i) 1,621 PRSUs granted on 2/24/2014 and attained on 2/24/2015; and (ii) 3,526 PRSUs granted on 2/23/2015 and attained on 2/23/2016, each of which shall vest in full (restrictions lapse) three years from the grant date.

6. This option is fully vested and exercisable.

7. Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 24, 2017.

8. Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 23, 2018.

9. Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 17, 2019.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	Michael Friedlander, Attorney-In-Fact for Maureen J. MacInnis	04/18/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.